Voloridge Investment Management
XERS icon

Voloridge Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Voloridge Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.15M Sell
370,116
-441,013
-54% -$2.92M 0.01% 816
2025
Q4 		$6.37M Sell
811,129
-223,424
-22% -$1.76M 0.02% 704
2025
Q3 		$8.42M Buy
1,034,553
+40,172
+4% +$267K 0.03% 594
2025
Q2 		$4.64M Sell
994,381
-356,733
-26% -$1.63M 0.02% 766
2025
Q1 		$7.42M Buy
+1,351,114
New +$5.45M 0.03% 670
2021
Q1 		– Sell
-134,737
Closed -$663K – 1699
2020
Q4 		$663K Sell
134,737
-284,301
-68% -$1.42M 0.01% 1078
2020
Q3 		$2.48M Buy
+419,038
New +$1.68M 0.02% 651

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voloridge Investment Management's XERS Position: Q1 2026 in Review

Voloridge Investment Management reduced its Xeris Biopharma Holdings (XERS) stake by 54% in Q1 2026, selling an estimated $2.92M and leaving 370,116 shares worth $2.15M. The position accounts for 0.01% of the portfolio, ranked #816.

Voloridge Investment Management first reported a position in XERS in Q3 2020 and has held it in 7 quarters since. The position peaked at $8.42M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Voloridge Investment Management held 370,116 shares of Xeris Biopharma Holdings worth $2.15M as of Q1 2026.
  • Voloridge Investment Management sold 441,013 Xeris Biopharma Holdings shares in Q1 2026, an estimated $2.92M.
  • Xeris Biopharma Holdings made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #816 holding.
  • Voloridge Investment Management first reported a position in Xeris Biopharma Holdings in Q3 2020 and has held it in 7 quarters since.
  • Voloridge Investment Management's Xeris Biopharma Holdings position peaked at $8.42M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.